281 related articles for article (PubMed ID: 22123930)
1. HIV-associated PML: changing epidemiology and clinical approach.
Simpson DM
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S24-7. PubMed ID: 22123930
[TBL] [Abstract][Full Text] [Related]
2. JC virus DNA in cerebrospinal fluid of human immunodeficiency virus-infected patients: predictive value for progressive multifocal leukoencephalopathy.
McGuire D; Barhite S; Hollander H; Miles M
Ann Neurol; 1995 Mar; 37(3):395-9. PubMed ID: 7695239
[TBL] [Abstract][Full Text] [Related]
3. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
Kishida S
Brain Nerve; 2007 Feb; 59(2):125-37. PubMed ID: 17380777
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
[TBL] [Abstract][Full Text] [Related]
5. Highly active antiretroviral therapy and progressive multifocal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response.
Giudici B; Vaz B; Bossolasco S; Casari S; Brambilla AM; Lüke W; Lazzarin A; Weber T; Cinque P
Clin Infect Dis; 2000 Jan; 30(1):95-9. PubMed ID: 10619739
[TBL] [Abstract][Full Text] [Related]
6. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ
Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651
[TBL] [Abstract][Full Text] [Related]
7. New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab.
Lima MA; Koralnik IJ
J Neurovirol; 2005; 11 Suppl 3():52-7. PubMed ID: 16540456
[TBL] [Abstract][Full Text] [Related]
8. Visual loss secondary to acquired immunodeficiency virus-related progressive multifocal leukoencephalopathy demonstrating clinical improvement with highly active antiretroviral therapy.
Diller R; Thompson K
Optometry; 2007 Feb; 78(2):63-70. PubMed ID: 17258160
[TBL] [Abstract][Full Text] [Related]
9. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
[TBL] [Abstract][Full Text] [Related]
10. [Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: the clinical, neuroimaging, virological and evolutive characteristics in 35 patients].
Asensi V; Cartón JA; Maradona JA; Oña M; Melón S; Martín-Roces ER; Asensi JM; Arribas JM
Med Clin (Barc); 1999 Sep; 113(6):210-4. PubMed ID: 10472609
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy.
Yoon CJ
AIDS Read; 2006 Jun; 16(6):304-6, 309. PubMed ID: 16795920
[No Abstract] [Full Text] [Related]
12. [Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy].
Imamura E; Yamashita H; Fukuhara T; Sawa H; Nagashima K; Kuwabara M; Tokinobu H
Rinsho Shinkeigaku; 2007 Oct; 47(10):650-6. PubMed ID: 18095498
[TBL] [Abstract][Full Text] [Related]
13. JC virus genotypes in France: molecular epidemiology and potential significance for progressive multifocal leukoencephalopathy.
Dubois V; Moret H; Lafon ME; Brodard V; Icart J; Ruffault A; Guist'hau O; Buffet-Janvresse C; Abbed K; Dussaix E; Ingrand D
J Infect Dis; 2001 Jan; 183(2):213-217. PubMed ID: 11110646
[TBL] [Abstract][Full Text] [Related]
14. AIDS-related progressive multifocal leukoencephalopathy (PML): a retrospective study from Pretoria, South Africa.
Schutte CM; Ranchhod N; Kakaza M; Pillay M
S Afr Med J; 2013 Apr; 103(6):399-401. PubMed ID: 23725960
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of aids related PML with HAART and cidofovir.
Zimmermann T; Stingele K; Hartmann M; Haas J; von Einsiedel R; Wildemann B
Eur J Med Res; 2001 May; 6(5):190-62. PubMed ID: 11410399
[TBL] [Abstract][Full Text] [Related]
16. [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].
Kishida S
No To Shinkei; 2007 Feb; 59(2):125-37. PubMed ID: 17315754
[TBL] [Abstract][Full Text] [Related]
17. Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy.
Razonable RR; Aksamit AJ; Wright AJ; Wilson JW
Mayo Clin Proc; 2001 Nov; 76(11):1171-5. PubMed ID: 11702907
[TBL] [Abstract][Full Text] [Related]
18. [Clinico-epidemiologic manifestations of progressive multifocal leukoencephalopathy in patients with acquired immunodeficiency syndrome (AIDS)].
Iglesias Oliva L; Nan D; García-Palomo JD; Fariñas MC
An Med Interna; 2000 Apr; 17(4):178-81. PubMed ID: 10893767
[TBL] [Abstract][Full Text] [Related]
19. A review of progressive multifocal leukoencephalopathy in persons with and without AIDS.
Dworkin MS
Curr Clin Top Infect Dis; 2002; 22():181-95. PubMed ID: 12520654
[No Abstract] [Full Text] [Related]
20. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
